NO963572L - Inhibin-sammensetninger og fremgangsmåter for bruk av disse - Google Patents

Inhibin-sammensetninger og fremgangsmåter for bruk av disse

Info

Publication number
NO963572L
NO963572L NO963572A NO963572A NO963572L NO 963572 L NO963572 L NO 963572L NO 963572 A NO963572 A NO 963572A NO 963572 A NO963572 A NO 963572A NO 963572 L NO963572 L NO 963572L
Authority
NO
Norway
Prior art keywords
protein
heterologous protein
inhibin
heterologous
fused
Prior art date
Application number
NO963572A
Other languages
English (en)
Norwegian (no)
Other versions
NO963572D0 (no
Inventor
William C Fioretti
Konstantin Kousoulas
Daniel G Satterlee
Original Assignee
Agritech Technologies Ltd
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agritech Technologies Ltd, Univ Louisiana State filed Critical Agritech Technologies Ltd
Publication of NO963572D0 publication Critical patent/NO963572D0/no
Publication of NO963572L publication Critical patent/NO963572L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO963572A 1994-02-28 1996-08-27 Inhibin-sammensetninger og fremgangsmåter for bruk av disse NO963572L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20296494A 1994-02-28 1994-02-28
PCT/US1995/002795 WO1995022980A1 (en) 1994-02-28 1995-02-28 Inhibin compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
NO963572D0 NO963572D0 (no) 1996-08-27
NO963572L true NO963572L (no) 1996-10-25

Family

ID=22751927

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963572A NO963572L (no) 1994-02-28 1996-08-27 Inhibin-sammensetninger og fremgangsmåter for bruk av disse

Country Status (18)

Country Link
EP (1) EP0804219B1 (da)
JP (1) JPH09510702A (da)
CN (1) CN1149258A (da)
AT (1) ATE220554T1 (da)
AU (1) AU704737B2 (da)
BR (1) BR9507426A (da)
CA (1) CA2184183C (da)
DE (1) DE69527439T2 (da)
DK (1) DK0804219T3 (da)
ES (1) ES2181771T3 (da)
FI (1) FI963325L (da)
MX (1) MX9603702A (da)
NO (1) NO963572L (da)
NZ (1) NZ282981A (da)
PL (1) PL184202B1 (da)
PT (1) PT804219E (da)
RU (1) RU2170100C2 (da)
WO (1) WO1995022980A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786179A (en) * 1994-02-28 1998-07-28 Agritech Technologies Ltd. Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same
US5747659A (en) * 1994-02-28 1998-05-05 Agritech Technologies, Ltd. Fusion gene products encoding avian alpha subunit inhibin protein, or an immunogenic fragment thereof, and a carrier protein
WO2004043141A2 (en) * 2002-11-07 2004-05-27 Agritech Technology, Ltd Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians
PT2548560E (pt) 2005-06-23 2015-09-22 Isis Pharmaceuticals Inc Composições e métodos de modulação da excisão-união de smn2
CN101253198A (zh) 2005-08-29 2008-08-27 独立行政法人科学技术振兴机构 使用鸵鸟产生的抗体及其制备方法
KR20220084437A (ko) 2009-06-17 2022-06-21 바이오젠 엠에이 인코포레이티드 대상에게서 ｓｍｎ２ 스플라이싱을 조정하기 위한 조성물 및 방법
EP2943225A4 (en) 2013-01-09 2016-07-13 Ionis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR MODULATING SMN2 DISTRIBUTION IN THE BODY OF A PATIENT
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica
US20170044538A1 (en) 2014-04-17 2017-02-16 Biogen Ma Inc. Compositions and Methods for Modulation of SMN2 Splicing in a Subject
WO2016040748A1 (en) 2014-09-12 2016-03-17 Ionis Pharmaceuticals, Inc. Compositions and methods for detection of smn protein in a subject and treatment of a subject
US11198867B2 (en) 2016-06-16 2021-12-14 Ionis Pharmaceuticals, Inc. Combinations for the modulation of SMN expression
CN110551744A (zh) * 2019-09-18 2019-12-10 普健生物（武汉）科技有限公司 一种人抑制素a的核苷酸序列及重组表达人抑制素a的方法
AU2021225957A1 (en) 2020-02-28 2022-09-08 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating SMN2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom

Also Published As

Publication number Publication date
DK0804219T3 (da) 2002-11-11
CN1149258A (zh) 1997-05-07
FI963325A7 (fi) 1996-10-21
NO963572D0 (no) 1996-08-27
PT804219E (pt) 2002-12-31
RU2170100C2 (ru) 2001-07-10
FI963325L (fi) 1996-10-21
CA2184183A1 (en) 1995-08-31
DE69527439D1 (de) 2002-08-22
CA2184183C (en) 2005-02-08
EP0804219A1 (en) 1997-11-05
AU704737B2 (en) 1999-05-06
AU2095995A (en) 1995-09-11
PL316628A1 (en) 1997-02-03
MX9603702A (es) 1997-12-31
JPH09510702A (ja) 1997-10-28
ES2181771T3 (es) 2003-03-01
ATE220554T1 (de) 2002-08-15
EP0804219B1 (en) 2002-07-17
BR9507426A (pt) 1997-09-16
FI963325A0 (fi) 1996-08-27
PL184202B1 (pl) 2002-09-30
EP0804219A4 (en) 1999-02-24
DE69527439T2 (de) 2003-02-20
WO1995022980A1 (en) 1995-08-31
NZ282981A (en) 1998-08-26

Similar Documents

Publication Publication Date Title
NO963572D0 (no) Inhibin-sammensetninger og fremgangsmåter for bruk av disse
Solari et al. Biosynthesis of the IgA antibody receptor: a model for the transepithelial sorting of a membrane glycoprotein
CA2290485A1 (en) Method for the production of non-immunogenic proteins
ATE235250T1 (de) Inhibinzusammensetzungen und verfahren zur erhöhung der reproduzierenden leistung
ATE262348T1 (de) Mittel zur verabreichung von antigenen
IT1203672B (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
KR900700116A (ko) 뼈-유도 단백질
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
BR9809656A (pt) Composição imunopotencializante
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
RU2008120299A (ru) СПОСОБЫ ПОЛУЧЕНИЯ КОМПОЗИЦИЙ, ВКЛЮЧАЮЩИХ ХИТШОКОВЫЕ БЕЛКИ ИЛИ α-2-МАКРОГЛОБУЛИН, ПРИГОДНЫХ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ И ИНФЕКЦИОННОГО ЗАБОЛЕВАНИЯ
DE69331758D1 (de) Fibrinogen-bildungsprotein
AU575843B2 (en) Growth hormone releasing peptides
BR9713847A (pt) Polipeptìdeo isolado codificado por um gene semelhante a lipase, composição, composição farmacêutica, fragmento antigênico, ácido nucleico isolado, vetor, célula recombinante, anticorpo, célula de hibridoma, processos para preparar um polipeptìdeo, para triar agonistas ou antagonistas de atividade llg, para a hidrólise enzimática de um éster de fosfatidilcolina, e para melhorar o perfil de lipìdeo no soro de um humano ou outro animal tendo um perfil de lipìdeo indesejável, e, camundongo transgênico.
ATE141283T1 (de) Verfahren zur reinigung eines hochglykosylierten proteins
Cencič et al. The porcine trophoblastic interferon‐γ, secreted by a polarized epithelium, has specific structural and biochemical properties
PT866861E (pt) Clonagem molecular e caracterizacao de moleculas relacionadas com relaxina e com a familia dos ligandos da insulina
Yakulis et al. Production of Fe fragments of IgM
ATE465751T1 (de) Verfahren zur vorbeugung und linderung angiogener erkrankungen durch impfung mit dem rezeptor für gbs-toxin (cm101)
AU633967B2 (en) Cleavage promoter
Pass et al. Generation of antibodies to the urokinase receptor (uPAR) by DNA immunization of uPAR knockout mice: Membrane‐bound uPAR is not required for an antibody response
Pierre et al. Mouse secretory component
Trenkle et al. Studies on pituitary lactogenic hormone. XXI. Immunochemical studies of the sheep hormone
Sangadala et al. Immunological characterization of deglycosylated human and swine trachea and Cowper's gland mucin glycoproteins
Peng et al. Cross-reactivity of antibodies to chicken brain choline acetyltransferase with mammalian enzyme